HUP0202710A3 - Vitronectin receptor antagonists, pharmaceutical compositions containing them and their use - Google Patents
Vitronectin receptor antagonists, pharmaceutical compositions containing them and their useInfo
- Publication number
- HUP0202710A3 HUP0202710A3 HU0202710A HUP0202710A HUP0202710A3 HU P0202710 A3 HUP0202710 A3 HU P0202710A3 HU 0202710 A HU0202710 A HU 0202710A HU P0202710 A HUP0202710 A HU P0202710A HU P0202710 A3 HUP0202710 A3 HU P0202710A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- receptor antagonists
- vitronectin receptor
- vitronectin
- Prior art date
Links
- 102100022337 Integrin alpha-V Human genes 0.000 title 1
- 108010048673 Vitronectin Receptors Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- External Artificial Organs (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15278099P | 1999-09-07 | 1999-09-07 | |
| PCT/US2000/024514 WO2001017959A2 (en) | 1999-09-07 | 2000-09-07 | Vitronectin receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202710A2 HUP0202710A2 (hu) | 2002-12-28 |
| HUP0202710A3 true HUP0202710A3 (en) | 2003-06-30 |
Family
ID=22544416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202710A HUP0202710A3 (en) | 1999-09-07 | 2000-09-07 | Vitronectin receptor antagonists, pharmaceutical compositions containing them and their use |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1218005B1 (hu) |
| JP (1) | JP4685307B2 (hu) |
| KR (1) | KR100711170B1 (hu) |
| CN (1) | CN1236767C (hu) |
| AR (1) | AR025589A1 (hu) |
| AT (1) | ATE284870T1 (hu) |
| AU (1) | AU768918B2 (hu) |
| BR (1) | BR0013749A (hu) |
| CA (1) | CA2384671A1 (hu) |
| CO (1) | CO5200845A1 (hu) |
| CZ (1) | CZ2002822A3 (hu) |
| DE (1) | DE60016769T2 (hu) |
| EG (1) | EG24179A (hu) |
| ES (1) | ES2234658T3 (hu) |
| GC (1) | GC0000203A (hu) |
| HK (1) | HK1049110B (hu) |
| HU (1) | HUP0202710A3 (hu) |
| IL (2) | IL148325A0 (hu) |
| MX (1) | MXPA02002455A (hu) |
| NO (1) | NO322109B1 (hu) |
| NZ (1) | NZ517296A (hu) |
| PE (1) | PE20010582A1 (hu) |
| PL (1) | PL200404B1 (hu) |
| PT (1) | PT1218005E (hu) |
| TR (1) | TR200200614T2 (hu) |
| TW (1) | TWI255813B (hu) |
| UY (1) | UY26329A1 (hu) |
| WO (1) | WO2001017959A2 (hu) |
| ZA (1) | ZA200201780B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6531494B1 (en) | 2001-08-29 | 2003-03-11 | Pharmacia Corporation | Gem-substituted αvβ3 antagonists |
| US6982263B2 (en) | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
| GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
| AU2005219737B2 (en) * | 2004-03-05 | 2009-11-19 | Taisho Pharmaceutical Co., Ltd. | Thiazole derivative |
| SG186989A1 (en) | 2010-07-14 | 2013-02-28 | Novartis Ag | Ip receptor agonist heterocyclic compounds |
| AR089698A1 (es) | 2012-01-13 | 2014-09-10 | Novartis Ag | Compuestos heterociclicos antagonistas del receptor ip |
| JP2016507582A (ja) | 2013-02-13 | 2016-03-10 | ノバルティス アーゲー | Ｉｐ受容体アゴニスト複素環式化合物 |
| CN108675954A (zh) * | 2018-04-03 | 2018-10-19 | 爱斯特（成都）生物制药股份有限公司 | 2-氨基-3-羟甲基吡啶的一种制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08325264A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規２−芳香環置換−３−フェニルプロピオン酸またはアクリル酸誘導体 |
| JPH08325263A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規２−アミノ−３−フェニルプロピオン酸誘導体 |
| TR199801255T2 (xx) * | 1995-12-29 | 1998-10-21 | Smithkline Beecham Corporation | Vitronektin resept�r antagonistleri. |
| AU8750298A (en) * | 1997-08-28 | 1999-03-22 | Ono Pharmaceutical Co. Ltd. | Peroxisome proliferator-activated receptor controllers |
| AR015446A1 (es) * | 1997-09-19 | 2001-05-02 | Smithkline Beecham Corp | Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios |
| CN1299282A (zh) * | 1998-03-10 | 2001-06-13 | 史密丝克莱恩比彻姆公司 | 玻连蛋白受体拮抗剂 |
| JP2002522540A (ja) * | 1998-08-13 | 2002-07-23 | メルク エンド カムパニー インコーポレーテッド | インテグリン受容体拮抗薬 |
-
2000
- 2000-09-05 EG EG20001132A patent/EG24179A/xx active
- 2000-09-06 CO CO00067158A patent/CO5200845A1/es not_active Application Discontinuation
- 2000-09-06 UY UY26329A patent/UY26329A1/es not_active Application Discontinuation
- 2000-09-06 PE PE2000000909A patent/PE20010582A1/es not_active Application Discontinuation
- 2000-09-07 CA CA002384671A patent/CA2384671A1/en not_active Abandoned
- 2000-09-07 PL PL354176A patent/PL200404B1/pl not_active IP Right Cessation
- 2000-09-07 JP JP2001521706A patent/JP4685307B2/ja not_active Expired - Fee Related
- 2000-09-07 ES ES00961619T patent/ES2234658T3/es not_active Expired - Lifetime
- 2000-09-07 NZ NZ517296A patent/NZ517296A/en unknown
- 2000-09-07 DE DE60016769T patent/DE60016769T2/de not_active Expired - Lifetime
- 2000-09-07 TR TR2002/00614T patent/TR200200614T2/xx unknown
- 2000-09-07 AU AU73543/00A patent/AU768918B2/en not_active Ceased
- 2000-09-07 KR KR1020027002979A patent/KR100711170B1/ko not_active IP Right Cessation
- 2000-09-07 AT AT00961619T patent/ATE284870T1/de not_active IP Right Cessation
- 2000-09-07 BR BR0013749-9A patent/BR0013749A/pt not_active Application Discontinuation
- 2000-09-07 IL IL14832500A patent/IL148325A0/xx active IP Right Grant
- 2000-09-07 EP EP00961619A patent/EP1218005B1/en not_active Expired - Lifetime
- 2000-09-07 AR ARP000104681A patent/AR025589A1/es unknown
- 2000-09-07 MX MXPA02002455A patent/MXPA02002455A/es active IP Right Grant
- 2000-09-07 CN CNB008126135A patent/CN1236767C/zh not_active Expired - Fee Related
- 2000-09-07 CZ CZ2002822A patent/CZ2002822A3/cs unknown
- 2000-09-07 PT PT00961619T patent/PT1218005E/pt unknown
- 2000-09-07 HU HU0202710A patent/HUP0202710A3/hu unknown
- 2000-09-07 WO PCT/US2000/024514 patent/WO2001017959A2/en active IP Right Grant
- 2000-09-09 GC GCP2000894 patent/GC0000203A/en active
- 2000-09-25 TW TW089118280A patent/TWI255813B/zh not_active IP Right Cessation
-
2002
- 2002-02-21 IL IL148325A patent/IL148325A/en not_active IP Right Cessation
- 2002-03-04 ZA ZA200201780A patent/ZA200201780B/xx unknown
- 2002-03-06 NO NO20021113A patent/NO322109B1/no not_active IP Right Cessation
- 2002-12-23 HK HK02109309.5A patent/HK1049110B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
| HUP0303081A3 (en) | Thrombin receptor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0301654A2 (en) | Novel n-pyrimidinyl-sulfamides, their use as endothelin receptor antagonists and pharmaceutical compositions containing them | |
| HUP0203638A3 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use | |
| HUP0303339A3 (en) | Heteroaryl urea neuropeptide y y5 receptor antagonists, their use and pharmaceutical compositions containing them | |
| HUP0401643A3 (en) | Substituted urea neuropeptide y y5 receptor antagonists, their use and pharmaceutical compositions containing them | |
| HUP0302382A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| HUP0203528A3 (en) | Piperidine derivatives useful as ccr5 antagonists, pharmaceutical compositions containing them and their use | |
| HUP0204272A3 (en) | Corticotropin releasing factor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0200996A3 (en) | Amine derivatives, pharmaceutical compositions containing them and their use | |
| EP1194151A4 (en) | ANTAGONISTS OF THE INTEGRIN RECEPTORS | |
| EP1229910A4 (en) | integrin | |
| HUP0300599A3 (en) | Il-8 receptor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0204113A3 (en) | Novel integrin receptor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0302003A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| HUP0200707A2 (en) | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists pharmaceutical compositions containing them and their use | |
| HUP0302614A3 (en) | Il-8 receptor antagonists and pharmaceutical compositions containing them | |
| HUP0200080A3 (en) | 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists and pharmaceutical compositions containing the compounds | |
| HUP0202710A3 (en) | Vitronectin receptor antagonists, pharmaceutical compositions containing them and their use | |
| HUP0201300A3 (en) | Il-8 receptor antagonist imidazoidinylidene-2-imino derivatives and pharmaceutical compositions containing them | |
| HUP0500079A3 (en) | Chemokine receptor antagonists, their use and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |